Industry Strength Score
17/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
SOLVENTUM CORP (SOLV) Stock Price & Overview
NYSE:SOLV • US83444M1018
Current stock price
66.63 USD
-0.73 (-1.08%)
At close:
66.63 USD
0 (0%)
After Hours:
The current stock price of SOLV is 66.63 USD. Today SOLV is down by -1.08%. In the past month the price increased by 4.81%. In the past year, price decreased by -1.46%.
SOLV Key Statistics
52-Week Range62.38 - 88.2
Current SOLV stock price positioned within its 52-week range.
1-Month Range62.38 - 71.42
Current SOLV stock price positioned within its 1-month range.
- Market Cap
- 11.554B
- P/E
- 10.92
- Fwd P/E
- 10.12
- EPS (TTM)
- 6.10
- Dividend Yield
- N/A
SOLV Stock Performance
Today
-1.08%
1 Week
-2.76%
1 Month
+4.81%
3 Months
-13.43%
Longer-term
6 Months -3.49%
1 Year -1.46%
2 Years +12.29%
3 Years N/A
5 Years N/A
10 Years N/A
SOLV Stock Chart
SOLV Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SOLV. When comparing the yearly performance of all stocks, SOLV is a bad performer in the overall market: 78.41% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
SOLV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SOLV. SOLV has an excellent profitability rating, but there are concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SOLV Earnings
On February 26, 2026 SOLV reported an EPS of 1.57 and a revenue of 2.00B. The company beat EPS expectations (2.92% surprise) and missed revenue expectations (-0.15% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported$1.57
Revenue Reported1.998B
EPS Surprise 2.92%
Revenue Surprise -0.15%
SOLV Forecast & Estimates
21 analysts have analysed SOLV and the average price target is 87.95 USD. This implies a price increase of 31.99% is expected in the next year compared to the current price of 66.63.
For the next year, analysts expect an EPS growth of 7.95% and a revenue growth -1.18% for SOLV
Analysts
Analysts73.33
Price Target87.95 (32%)
EPS Next Y7.95%
Revenue Next Year-1.18%
SOLV Index Membership
SOLV is currently included in the following stock indexes tracked on ChartMill.
SOLV Financial Highlights
Over the last trailing twelve months SOLV reported a non-GAAP Earnings per Share(EPS) of 6.1. The EPS decreased by -8.82% compared to the year before.
Income Statements
Revenue(TTM)8.32B
Net Income(TTM)1.56B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.69% | ||
| ROA | 10.89% | ||
| ROE | 30.82% | ||
| Debt/Equity | 1 |
Chartmill High Growth Momentum
EPS Q2Q%11.35%
Sales Q2Q%-3.66%
EPS 1Y (TTM)-8.82%
Revenue 1Y (TTM)0.86%
SOLV Ownership
Ownership
Inst Owners73.51%
Shares173.41M
Float147.37M
Ins Owners0.19%
Short Float %4.33%
Short Ratio4.86
SOLV Industry Overview
SOLV operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 34 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
32/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
27%
Outperformed 27% of sub-industries
3 Month Rank
21%
Outperformed 21% of sub-industries
6 Month Rank
25%
Outperformed 25% of sub-industries
Industry Fundamentals & Breadth
- Members
- 34
- New Highs
- 2.9%
- New Lows
- 14.7%
- Average ROE
- 12.6%
- Average Profit Margin
- 7.9%
- Average Operating Margin
- 10.8%
- Average P/E
- 24.7
- Average Fwd P/E
- 21.6
- Average Debt/Equity
- 0.9
SOLV Latest News, Press Relases and Analysis
SOLV Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.84 | 58.42B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.27 | 12.606B | ||
| COO | COOPER COS INC/THE | 12.29 | 12.272B | ||
| LNTH | LANTHEUS HOLDINGS INC | 16.14 | 5.498B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 13.84 | 4.067B | ||
| ICUI | ICU MEDICAL INC | 14.37 | 2.979B | ||
| HAE | HAEMONETICS CORP/MASS | 11.19 | 2.792B | ||
| XRAY | DENTSPLY SIRONA INC | 8.09 | 2.347B | ||
| NEOG | NEOGEN CORP | 28.1 | 2.046B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.26 | 1.477B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.305B | ||
| AVNS | AVANOS MEDICAL INC | 24.15 | 1.145B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SOLV
Company Profile
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 20,000 full-time employees. The company went IPO on 2024-03-26. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
Company Info
IPO: 2024-03-26
SOLVENTUM CORP
C/O 3M Company, 3M Center, Building 275-6W-02
ST. PAUL MINNESOTA US
Employees: 20000
Phone: 18009279800
SOLVENTUM CORP / SOLV FAQ
Can you describe the business of SOLVENTUM CORP?
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 20,000 full-time employees. The company went IPO on 2024-03-26. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
What is the stock price of SOLVENTUM CORP today?
The current stock price of SOLV is 66.63 USD. The price decreased by -1.08% in the last trading session.
Does SOLV stock pay dividends?
SOLV does not pay a dividend.
What is the ChartMill rating of SOLVENTUM CORP stock?
SOLV has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for SOLV stock?
21 analysts have analysed SOLV and the average price target is 87.95 USD. This implies a price increase of 31.99% is expected in the next year compared to the current price of 66.63.
Can you provide the PE ratio for SOLV stock?
The PE ratio for SOLVENTUM CORP (SOLV) is 10.92. This is based on the reported non-GAAP earnings per share of 6.1 and the current share price of 66.63 USD.
Can you provide the growth outlook for SOLVENTUM CORP?
The Revenue of SOLVENTUM CORP (SOLV) is expected to decline by -1.18% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.